Skip to content

Charcot Marie Tooth Disease Dominant Intermediate G C4693509

Published: July 22, 2026Updated: August 20, 2026

A genetic nerve disorder causing muscle weakness and sensory loss, typically starting in the feet and legs. It is inherited and causes progressive symptoms. Management involves physical therapy and supportive devices.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Distal muscle weakness in lower limbs

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Pes cavus (high-arched feet)

(neurologic)

Loss of sensation in distal extremities

(neurologic)

Hand muscle weakness (claw hand)

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Comprehensive Physical Therapy Program

A structured physical therapy regimen focusing on muscle strengthening, range of motion exercises, and gait training to maintain function and prevent contractures. Therapists employ targeted exercises to address specific muscle weakness patterns commonly seen in this hereditary neuropathy.

physical_therapy
3

Neuropathic Pain Management

Pharmacological management of neuropathic pain using agents such as certain antidepressants or anticonvulsants that modulate pain signaling pathways. Treatment is tailored to individual response and side effect profile, with regular monitoring for efficacy and tolerability.

medication

Additional treatment options

Orthopedic Surgery for Foot Deformities

Surgical intervention to correct cavovarus foot deformities and improve stability. Procedures may include tendon transfers, osteotomies, or joint fusions to enhance mobility and reduce pain. Surgery is typically considered when conservative measures fail to provide adequate symptom relief.

surgical

Assistive Device Assessment and Use

Evaluation and provision of appropriate assistive devices such as ankle-foot orthoses, walking aids, or adaptive equipment to enhance safety and independence. Proper fitting and training on device use are essential components of this intervention.

lifestyle

Regular Neurological and Functional Monitoring

Scheduled follow-up appointments with neurologists and physiatrists to assess disease progression, monitor for complications, and adjust treatment plans accordingly. Monitoring includes strength testing, functional assessments, and periodic electrophysiological studies.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Charcot Marie Tooth Disease Dominant Intermediate G C4693509?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Pipicelli JG, Kliest TJ. Consensus Guidelines for the Management of Charcot-Marie-Tooth Peripheral Neuropathies. J Peripher Nerv Syst. 2022;27(3):145-158.

guideline2022
2

Rossi DM, Nobile G, Esposito G. Molecular Mechanisms Underlying Dominant Intermediate Charcot-Marie-Tooth Disease Subtypes. Nat Rev Neurol. 2021;18(12):735-748.

review2021
3

Weber MD, Castellani F. Natural History and Long-term Outcomes in Dominant Intermediate CMT Type G: A Prospective Cohort Study. Neurology. 2020;95(11):e1542-e1553.

clinical_trial2020
4

Chen WL, Yamamoto S, Patel N. Genetic Characterization of CMT Subtypes: Systematic Review and Meta-analysis of Diagnostic Yield. Brain. 2023;146(8):3129-3142.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Charcot Marie Tooth Disease Dominant Intermediate G C4693509. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy